Drug Trial Radar · NCT05096494
Safety and Efficacy of SP-103 in Subjects With Moderate to Severe Acute Lower Back Pain
Last checked: Nov 20, 2026Latest source record: Jul 6, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
76
Actual
Start
Apr 29, 2022
Primary completion
May 30, 2023
Study completion May 30, 2023
Sponsor
- Lead sponsor
- Scilex Pharmaceuticals, Inc.Industry
- Sponsor type
- Industry
- Collaborators
- Worldwide Clinical Trials
- First posted
- Oct 27, 2021
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a Phase 2, randomized, double-blind, placebo-controlled, parallel group, multicenter study to evaluate the safety and efficacy of SP-103 in subjects with moderate to severe acute lower back pain.
Conditions
- Moderate to Severe Acute Lower Back Pain
Interventions
SP-103Drug
SP-103 topical system is worn daily for 12 hours per day for 28 days
PlaceboDrug
Placebo topical system is worn daily for 12 hours per day, for 28 days
Primary outcomes
What the sponsor says the trial is designed to measure.
- Numeric Pain Rating Scale Summed Pain Intensity DifferenceTime frame: Day 1 to 7
Locations
10 sites in 1 country. Site status is shown where the registry gives one.
Arizona Research Center
Phoenix, Arizona
Costal Clinical Research Specialists
Fernandina Beach, Florida
Costal Clinical Research Specialists
Jacksonville, Florida
Horizon Clinical Research
Newnan, Georgia
Injury Care Research
Boise, Idaho
Chicago Anesthesia Research Specialists
Chicago, Illinois
Neuroscience Research Center
Overland Park, Kansas
Neuroscience Institute, Overlook Medical Center
Summit, New Jersey
Western Reserve Hospital
Cuyahoga Falls, Ohio
Scilex Research Site 08
Charleston, South Carolina
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.